FRIDAY, Oct. 24, 2025 (HealthDay News) — A family riven by divorce or separation could triple the risk of a child developing psoriasis later in life, a new study says. The severe stress caused by such family upheaval might tax a child’s immune system in ways that increase their chancesContinue Reading
40 percent of children achieved complete skin clearance at week 16 with Tremfya versus placeboContinue Reading
THURSDAY, Oct. 2, 2025 (HealthDay News) — Doctors nationwide are issuing urgent warnings about a viral food trend inspired by the hit Netflix movie “KPop Demon Hunters” that is causing serious scalding injuries in children and teens. The trend involves youth imitating a scene from the movie by eating extremelyContinue Reading
It is the first topical JAK inhibitor approved in the U.S. for pediatric atopic dermatitisContinue Reading
THURSDAY, Sept. 18, 2025 (HealthDay News) — People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, a new study says. Psoriasis patients taking GLP-1 drugs had a 78% lower risk of premature death and a 44% lower risk of heart attack, stroke orContinue Reading
THURSDAY, Sept. 4, 2025 (HealthDay News) — A new shampoo-like gel developed by researchers at Michigan State University could help protect cancer patients from a common and dreaded side effect of chemotherapy: Hair loss. The gel, which has been tested in animal models, is designed to be applied to theContinue Reading
Products may be contaminated with bacteria that can cause serious infectionsContinue Reading
WEDNESDAY, Aug. 6, 2025 (HealthDay News) — Needless fear of hair loss and brittle, discolored nails caused by cancer treatment might lead many patients to avoid or delay life-saving treatment, a new pilot study says. Many people misunderstand how common these side effects are during cancer treatment, according to findingsContinue Reading
MONDAY, Aug. 4, 2025 (HealthDay News) — Long after floodwaters recede, the impact of flooding on the health of older adults is profound, new research shows. Rates of hospitalizations for a range of conditions affecting the skin and nervous system, as well as poisonings, injuries or mental health woes were allContinue Reading
THURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczema (CHE). CHE is common condition marked by redness, itching and cracking on the hands and wrists. Anzupgo (delgocitinib cream) is approved for adults with moderate-to-severe CHEContinue Reading